FGF1 and central nervous system cancer: Given that a pro-tumorigenic role for acidic-FGF1 has not previously been established for glioma, we evaluated the effect of recombinant FGF1 on 320-GSCs in growth factor depleted media, revealing a dose-responsive increase in 320-GSC growth (Fig. 6h).